Toxoplasmosis in immunocompromised patients is a serious, life-threatening condition that requires rapid, appropriate treatment. Diagnosis is based on PCR, notably on blood samples. Systematic blood screening is carried out for patients most at risk, to detect the disease at an early stage. Detection of parasite DNA in blood in asymptomatic patients is possible, in the absence of Toxoplasma multiplication. It has previously been proposed a distinction of two entities: toxoplasmosis disease (clinical, biological and imaging evidence of toxoplasmosis) and toxoplasmosis infection (positive PCR in the blood in the absence of clinical or radiological evidence, without progression to toxoplasmosis). Since the clinical signs of toxoplasmosis are often aspecific, a positive PCR may be the first warning result, making it difficult to determine whether the patient will progress to toxoplasmosis disease or toxoplasmosis infection. In collaboration with the French National Reference Center for toxoplasmosis, we are proposing a retrospective multicenter study to identify possible clinical, biological or imaging criteria pointing to toxoplasmosis disease or toxoplasmosis infection as soon as the first T. gondii PCR result is positive in the blood.
Study Type
OBSERVATIONAL
Enrollment
100
CHU de Clermont-Ferrand
Clermont-Ferrand, France
Demographic data: age
expressed in years old
Time frame: 1 year
Demographic data: sex
choice between male/female
Time frame: 1 year
time between transplantation and positive T. gondii PCR
expressed in number of days
Time frame: 1 year
Underlying disease
for example: acute leukemia, solid organ transplant, ...
Time frame: 1 year
Ongoing anti-T. gondii prophylaxis
molecule name
Time frame: 1 year
PCR Ct value at diagnosis
number of cycle threshold
Time frame: 1 year
Outcome 1 month after first positive PCR
death or alive
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.